This article has no abstract; the first 100 words appear below.
Beginning in early May 2011, northern Germany was the principal site of a massive epidemic of bloody diarrhea and the hemolytic–uremic syndrome caused by Shiga-toxin–producing Escherichia coli. By the time the outbreak ended in early July, there were reports of more than 4000 illnesses, 800 cases of the hemolytic–uremic syndrome, and 50 deaths in Germany and in 15 other countries. As a result of remarkable efforts by public health officials, clinicians, and microbiologists who raced to control the outbreak and to treat its victims, much was learned. As reported in this issue of the Journal by Frank et al. . . .
Disclosure forms provided by the author are available with the full text of this article at NEJM.org.
This article (10.1056/NEJMe1110896) was published on October 26, 2011, at NEJM.org.
Source Information
From the Departments of Medicine and Microbiology, New York University Langone Medical Center, and the New York Harbor Department of Veterans Affairs Medical Center — all in New York.
HEPATITIS-B-VACCINES
CKD-Micro1
CKD Algorithm